Expanding transcatheter aortic valve replacement into uncharted indications

키워드

참고문헌 (44)

1. Ross J Jr, "Aortic stenosis", Circulation, 38(1 Suppl), pp.61~67 (1968)
2. Bonow RO, "Population-wide trends in aortic stenosis incidence and outcomes", Circulation, 131, pp.969~971 (2015)[DOI]
3. Eveborn GW, "The evolving epidemiology of valvular aortic stenosis. The Tromso study", Heart, 99, pp.396~400 (2013)[DOI]
4. Leon MB, "Transcatheter aorticvalve implantation for aortic stenosis in patients who cannot undergo surgery", N Engl J Med, 363, pp.1597~1607 (2010)[DOI]
5. Harken DE, "Aortic valve replacement with a caged ball valve", Am J Cardiol, 9, pp.292~299 (1962)[DOI]
6. Cribier A, "Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description", Circulation, 106, pp.3006~3008 (2002)[DOI]
7. ", TCTMD"[URL]
8. Tastet L, "Severe and asymptomatic aortic stenosis management challenge: knowing that we do not really know", Curr Treat Options Cardiovasc Med, 19, pp.33~ (2017)[DOI]
9. Iung B, "A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease", Eur Heart J, 24, pp.1231~1243 (2003)[DOI]
10. Cribier A, "Percutaneous transluminal valvuloplasty of acquired aortic stenosis in elderly patients: an alternative to valve replacement?", Lancet, 1, pp.63~67 (1986)
11. Cribier A, "Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience", J Am Coll Cardiol, 47, pp.1214~1223 (2006)[DOI]
12. Grube E, "Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study", Circulation, 114, pp.1616~1624 (2006)[DOI]
13. Barbash IM, "Overview of the 2011 Food and Drug Administration Circulatory System devices panel of the Medical Devices Advisory Committee meeting on the Edwards <TEX>$SAPIEN^{TM}$<", TEX> transcatheter heart valve, 2012, pp.125, 550~555
14. "Corevalve Extreme Risk approval letter" (2014)[URL]
15. Smith CR, "Transcatheter versus surgical aortic-valve replacement in high-risk patients", N Engl J Med, 364, pp.2187~2198 (2011)[DOI]
16. Kodali SK, "Two-year outcomes after transcatheter or surgical aortic-valve replacement", N Engl J Med, 366, pp.1686~1695 (2012)[DOI]
17. Mack MJ, "5-Year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial", Lancet, 385, pp.2477~2484 (2015)[DOI]
18. Adams DH, "Transcatheter aortic-valve replacement with a self-expanding prosthesis", N Engl J Med, 370, pp.1790~1798 (2014)[DOI]
19. Lange R, "First successful transapical aortic valve implantation with the Corevalve revalving system: a case report", Heart Surg Forum, 10, pp.E478~E479 (2007)[DOI]
20. [URL]
21. [URL]
22. [URL]
23. Nielsen HH, "A prospective, randomised trial of transapical transcatheter aortic valve implantation vs. surgical aortic valve replacement in operable elderly patients with aortic stenosis: the STACCATO trial", EuroIntervention, 8, pp.383~389 (2012)[DOI]
24. Thyregod HG, "Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1-year results from the all-comers NOTION Randomized Clinical Trial", J Am Coll Cardiol, 65, pp.2184~2194 (2015)[DOI]
25. Leon MB, "Transcatheter or surgical aortic-valve replacement in intermediate-risk patients", N Engl J Med, 374, pp.1609~1620 (2016)[DOI]
26. Reardon MJ, "Surgical or transcatheter aortic-valve replacement in intermediaterisk patients", N Engl J Med, 376, pp.1321~1331 (2017)[DOI]
27. (2015)[URL]
28. [URL]
29. (2016)[URL]
30. (2015)[URL]
31. [URL]
32. Kang DH, "Early surgery versus conventional treatment in asymptomatic very severe aortic stenosis", Circulation, 121, pp.1502~1509 (2010)[DOI]
33. Connolly HM, "Aortic valve replacement for aortic stenosis with severe left ventricular dysfunction. Prognostic indicators", Circulation, 95, pp.2395~2400 (1997)[DOI]
34. Nishimura RA, "2014 AHA", ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology, J Am Coll Cardiol, pp.2014, 63[DOI]
35. Taniguchi T, "Initial surgical versus conservative strategies in patients with asymptomatic severe aortic stenosis", J Am Coll Cardiol, 66, pp.2827~2838 (2015)[DOI]
36. Shively BK, "Evolving concepts about aortic stenosis", Cardiol Rev, 6, pp.325~333 (1998)
37. Edwards FH, "Development and validation of a risk prediction model for in-hospital mortality after transcatheter aortic valve replacement", JAMA Cardiol, 1, pp.46~52 (2016)[DOI]
38. "TAVR in-hospital mortality risk calculator" (2016)[URL]
39. Popma JJ, "Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery", J Am Coll Cardiol, 63, pp.1972~1981 (2014)[DOI]
40. Kim JB, "GDF-15 (growth differentiation factor 15) is associated with lack of ventricular recovery and mortality after transcatheter aortic valve replacement", Circ Cardiovasc Interv, 10, pp.e005594~ (2017)[DOI]
41. Lindman BR, "Prognostic utility of novel biomarkers of cardiovascular stress in patients with aortic stenosis undergoing valve replacement", Heart, 101, pp.1382~1388 (2015)[DOI]
42. Kobayashi Y, "Dynamic changes in aortic impedance after transcatheter aortic valve replacement and its impact on exploratory outcome", Int J Cardiovasc Imaging, 33, pp.1693~1701 (2017)[DOI]
43. Ito A, "Echocardiographic parameters predicting acute hemodynamically significant mitral regurgitation during transfemoral transcatheter aortic valve replacement", Echocardiography, 35, pp.353~360 (2018)[DOI]
44. Roule V, "Angles between the aortic root and the left ventricle assessed by MDCT are associated with the risk of aortic regurgitation after transcatheter aortic valve replacement", Heart Vessels, 33, pp.58~65 (2018)[DOI]

관련 논문AI추천